OBJECTIVE: To determine the prevalence of patients with type 1 diabetes mellitus who meet the glycemic and cardiovascular (CV) risk factors goals and the frequency of screening for diabetic complications in Brazil according to the American Diabetes Association guidelines. RESEARCH DESIGN AND METHODS: This was a cross-sectional, multicenter study conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. Data were obtained from 1774 adult patients (56.8% females, 57.2% Caucasians) aged 30.3 ± 9.8 years with diabetes duration of 14.3 ± 8.8 years. RESULTS: Systolic blood pressure was at goal in 40.3% and diastolic blood pressure was at goal in 26.6% of hypertensive patients. LDL cholesterol and HbA1c were at the goal in 45.2% and 13.2% of the patients, respectively. Overweight was presented in 25.6% and obesity in 6.9%. Among those with more than 5 years of disease, screening for retinopathy was performed in the preceding year in 70.1%. Nephropathy and feet complications were screened in 63.1% and 65.1%, respectively. CONCLUSIONS: The majority of patients did not meet metabolic control goals and a substantial proportion was not screened for diabetic complications. These issues may increase the risk of chronic complications and negatively impact public health.
OBJECTIVE: To determine the prevalence of patients with type 1 diabetes mellitus who meet the glycemic and cardiovascular (CV) risk factors goals and the frequency of screening for diabetic complications in Brazil according to the American Diabetes Association guidelines. RESEARCH DESIGN AND METHODS: This was a cross-sectional, multicenter study conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. Data were obtained from 1774 adult patients (56.8% females, 57.2% Caucasians) aged 30.3 ± 9.8 years with diabetes duration of 14.3 ± 8.8 years. RESULTS: Systolic blood pressure was at goal in 40.3% and diastolic blood pressure was at goal in 26.6% of hypertensivepatients. LDL cholesterol and HbA1c were at the goal in 45.2% and 13.2% of the patients, respectively. Overweight was presented in 25.6% and obesity in 6.9%. Among those with more than 5 years of disease, screening for retinopathy was performed in the preceding year in 70.1%. Nephropathy and feet complications were screened in 63.1% and 65.1%, respectively. CONCLUSIONS: The majority of patients did not meet metabolic control goals and a substantial proportion was not screened for diabetic complications. These issues may increase the risk of chronic complications and negatively impact public health.
Authors: Roberta Arnoldi Cobas; Marcos Bosi Ferraz; Alessandra Saldanha de Mattos Matheus; Lucianne Righeti Monteiro Tannus; Carlos Antonio Negrato; Luiz Antonio de Araujo; Sergio Atala Dib; Marilia Brito Gomes Journal: Bull World Health Organ Date: 2013-04-04 Impact factor: 9.408
Authors: Fernando M A Giuffrida; Alexis D Guedes; Eloa R Rocco; Denise B Mory; Patricia Dualib; Odelisa S Matos; Reine M Chaves-Fonseca; Roberta A Cobas; Carlos Antonio Negrato; Marilia B Gomes; Sergio A Dib Journal: Cardiovasc Diabetol Date: 2012-12-27 Impact factor: 9.951
Authors: Marilia Brito Gomes; Carlos Antonio Negrato; Roberta Cobas; Lucianne Righeti Monteiro Tannus; Paolla Ribeiro Gonçalves; Pedro Carlos Barreto da Silva; João Regis Ivar Carneiro; Alessandra Saldanha Mattos Matheus; Sergio Atala Dib; Mirela Jobim Azevedo; Márcia Nery; Melanie Rodacki; Lenita Zajdenverg; Renan Magalhães Montenegro Junior; Janice Sepulveda; Luis Eduardo Calliari; Deborah Jezini; Neuza Braga; Jorge L Luescher; Renata S Berardo; Maria Carmo Arruda-Marques; Renata M Noronha; Thais D Manna; Roberta Salvodelli; Fernanda G Penha; Milton C Foss; Maria C Foss-Freitas; Antonio C Pires; Fernando C Robles; Maria de Fátima S Guedes; Patricia Dualib; Saulo C Silva; Emerson Sampaio; Rosangela Rea; Ana Cristina R Faria; Balduino Tschiedel; Suzana Lavigne; Luis Henrique Canani; Alessandra T Zucatti; Marisa Helena C Coral; Daniela Aline Pereira; Luiz Antonio Araujo; Monica Tolentino; Hermelinda C Pedrosa; Flaviane A Prado; Nelson Rassi; Leticia B Araujo; Reine Marie C Fonseca; Alexis D Guedes; Odelissa S Matos; Catia C Palma; Rossana Azulay; Adriana C Forti; Cristina Façanha; Ana Paula Montenegro; Naira H Melo; Karla F Rezende; Alberto Ramos; João Soares Felicio; Flavia M Santos Journal: Diabetol Metab Syndr Date: 2014-05-31 Impact factor: 3.320
Authors: Marilia B Gomes; Lucianne Righeti Monteiro Tannus; Alessandra Saldanha de Mattos Matheus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Aline Tiemi Kano Silva; Carlos Antonio Negrato; Sergio Atala Dib; Melanie Rodacki; João Soares Felício; Luis Henrique Canani Journal: Int J Hypertens Date: 2013-03-04 Impact factor: 2.420
Authors: Alessandra Saldanha de Mattos Matheus; Lucianne Righeti Monteiro Tannus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Carlos Antonio Negrato; Marilia de Brito Gomes Journal: Int J Hypertens Date: 2013-03-04 Impact factor: 2.420
Authors: Marília B Gomes; Roberta A Cobas; Alessandra S Matheus; Lucianne R Tannus; Carlos Antonio Negrato; Melanie Rodacki; Neuza Braga; Marilena M Cordeiro; Jorge L Luescher; Renata S Berardo; Marcia Nery; Maria do Carmo A Arruda-Marques; Luiz E Calliari; Renata M Noronha; Thais D Manna; Lenita Zajdenverg; Roberta Salvodelli; Fernanda G Penha; Milton C Foss; Maria C Foss-Freitas; Antonio C Pires; Fernando C Robles; Mariadefátimas Guedes; Sergio A Dib; Patricia Dualib; Saulo C Silva; Janice Sepulvida; Henriqueta G Almeida; Emerson Sampaio; Rosangela Rea; Ana Cristina R Faria; Balduino Tschiedel; Suzana Lavigne; Gustavo A Cardozo; Mirela J Azevedo; Luis Henrique Canani; Alessandra T Zucatti; Marisa Helena C Coral; Daniela Aline Pereira; Luiz Antonio Araujo; Monica Tolentino; Hermelinda C Pedrosa; Flaviane A Prado; Nelson Rassi; Leticia B Araujo; Reine Marie C Fonseca; Alexis D Guedes; Odelissa S Matos; Manuel Faria; Rossana Azulay; Adriana C Forti; Cristina Façanha; Ana Paula Montenegro; Renan Montenegro; Naira H Melo; Karla F Rezende; Alberto Ramos; João Sooares Felicio; Flavia M Santos; Deborah L Jezini; Marilena M Cordeiro Journal: Diabetol Metab Syndr Date: 2012-10-29 Impact factor: 3.320